SuperworthLatigo Biotherapeutics shares outstanding LTGO
Diluted shares outstanding, averaged over each quarter, from 2025.
- Latest quarter, to Jun 30, 2026
- 935K
- On a year earlier
- +32.2%
- more shares
Latigo Biotherapeutics had 935K diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 32.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 935K | +32% | |
| Q1 FY26 | 908.9K | +28% | |
| Q2 FY25 | 707.5K | n/a | |
| Q1 FY25 | 707.5K | n/a |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Latigo Biotherapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.